The John Martin Foundation
EIN 300948144 Private Foundation
Possibly inactive.
Last 990-PF filing on record is from 2023
(3 years ago). Verify before investing time in an application.
Total Given 2017–2023
$40.0M
83 grants · $5.7M avg/year
based on 7 yrs of IRS 990-PF records on file
$1M+/yr
mid-tier
capacity
$222K
typical big bets · $107K–$488K
grant size
32%
supporter · 13/40 multi-year
repeat
$52.4M
Assets (2023)
40
Distinct Recipients
Focus Areas
Application Information
Accepts Unsolicited Proposals
No. Preselected Only
Contact Person
JOHN C MARTIN
Phone
(650) 798-5209
Deadlines
NO PRE-DETERMINED DEADLINES.
How to Apply
GRANT APPLICATIONS ARE RECEIVED FROM POTENTIAL GRANTEES WHOSE PROPOSED PROJECTS MUST BE FOR CHARITABLE, EDUCATIONAL OR SCIENTIFIC PURPOSES. THE APPLICATIONS INCLUDE QUALIFICATIONS AND EXPERIENCE OF THE GRANTEE ORGANIZATION AND THE CORRESPONDING PROJECT LEADER, DETAILS OF PROJECTS, INCLUDING BACKGROUND OF THE PROPOSED WORK, PROJECT LOCATION AND POPULATIONS, OBJECTIVES, WORK PLAN, MILESTONE AND TIMELINE, AND BUDGET. SUPPLEMENTARY DOCUMENTS SUCH AS TAX-EXEMPT CERTIFICATION OR NATIONAL REGISTRATION ARE ALSO SOUGHT IF AVAILABLE.
Restrictions
THE CONSIDERATIONS OF THE GRANTMAKING IS MADE TOWARDS THE STRATEGIC PRIORITIES OF THE FOUNDATION AS SET IN ITS ORGANIZATION'S STRATEGIC PLAN.
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2016 | N/A | $0 | $0 | N/A |
| 2017 | $2.1M | $36.1M | $39.0M | 10 |
| 2018 | $4.3M | $40.5M | $10.7M | 12 |
| 2020 | $4.8M | $45.9M | $8.1M | 16 |
| 2021 | $2.9M | $43.6M | $697K | 6 |
| 2022 | $13.7M | $60.5M | $27.1M | 18 |
| 2023 | $12.2M | $52.4M | $1.6M | 21 |
Grant Size Distribution
Based on 83 grants on record
Minimum
$1K
25th Pctl
$107K
Median
$222K
Average
$482K
75th Pctl
$488K
Maximum
$3.0M
Geographic Distribution
Officers & Directors
Grants Awarded (83 total)
| Purpose | ||||
|---|---|---|---|---|
| Pharm Access Foundation | Amsterdam, None | $3,000,000 | IMPROVE QUALITY OF MATERNAL AND CHILDCARE THROUGH M-TIBA CARE BUNDLES | 2022 |
| Liver Foundation West Bengal | West Bengal, None | $2,500,000 | JOHN C. MARTIN CENTRE FOR LIVER RESEARCH AND INNOVATIONS | 2022 |
| Arandaorg Inc | New York, NY | $2,000,000 | PILOTING THE ARANDA SUBSCRIPTION MODEL FOR ACCESS TO ANTIMICROBIALS IN BOTSWANA | 2023 |
| The Scripps Research Institute | La Jolla, CA | $2,000,000 | MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA | 2023 |
| The Scripps Research Institute | La Jolla, CA | $2,000,000 | MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA | 2023 |
| The Regents of the University of California San Diego | La Jolla, CA | $1,500,000 | UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER | 2022 |
| Pharm Access Foundation | Amsterdam, None | $1,490,003 | THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS A KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH | 2022 |
| Pharm Access Foundation | Amsterdam, None | $1,257,997 | THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH | 2022 |
| Pharm Access Foundation the Netherlands | Amsterdam, None | $1,250,000 | DEMOCRATIZING ACCESS TO BETTER HEALTHCARE IN KENYA THROUGH MOBILE TECHNOLOGY | 2018 |
| Pharm Access Foundation the Netherlands | Amsterdam, None | $1,250,000 | DEMOCRATIZING ACCESS TO BETTER HEALTHCARE IN KENYA THROUGH MOBILE TECHONOLOGY | 2020 |
| New Discovery Llc | Flushing, NY | $1,114,835 | TENOFOVIR IN COMBINATION OF HEPATITIS B VACCINE WITH THE OMISSION OF IMMUNE GLOBULIN TO PREVENT HEPATITIS B... | 2021 |
| Liver Foundation West Bengal | Kolkata, None | $1,000,000 | FOR DEVELOPMENT AND STRENGTHENING OF SERVICES AND PATIENT CARE INFRASTRUCTURE AT THE INDIAN INSTITUTE OF LIVER AND... | 2018 |
| Center for Disease Analysis Foundation | Lafayette, CO | $1,000,000 | POLARIS OBSERVATORY TO SUPPORT HEPATITIS ELIMINATION IN LOW AND MIDDLE-INCOME COUNTRIES | 2020 |
| Center for Disease Analysis Foundation | Lafayette, CO | $1,000,000 | POLARIS OBSERVATORY TO SUPPORT HEPATITIS ELIMINATION IN LOW AND MIDDLE-INCOME COUNTRIES | 2021 |
| Pharm Access Foundation | Amsterdam, None | $1,000,000 | THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS A KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH | 2023 |
| Pharm Access Foundation | Amsterdam, None | $1,000,000 | IMPROVE QUALITY OF MATERNAL AND CHILDCARE THROUGH M-TIBA CARE BUNDLES | 2023 |
| The Regents of the University of California San Diego | La Jolla, CA | $1,000,000 | UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER | 2023 |
| The Regents of the University of California San Diego | La Jolla, CA | $1,000,000 | UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER | 2022 |
| Center for Disease Analysis | Lafayette, CO | $956,062 | POLARIS OBSERVATORY | 2017 |
| President and Fellows of Harvard College | Cambridge, MA | $898,691 | MAKING THE CASE FOR VOLUNTARY LICENSING - CRAFTING A PATH FORWARD A ACCELERATE ACCESS TO MEDICINES | 2022 |
| Integral Global Consulting | Ne Atlanta, GA | $500,000 | LINKAGE TO CARE AND HEALTH EDUCATION IN UNDERSERVED COMMUNITIES OF ISLAMABAD, PAKISTAN | 2023 |
| New Discovery Llc | Flushing, NY | $476,496 | TENOFOVIR IN COMBINATION OF HEPATITIS B VACCINE WITH THE OMISSION OF IMMUNE GLOBULIN TO PREVENT HEPATITIS B... | 2022 |
| Center for Disease Analysis Foundation | Lafayette, CO | $410,520 | REDUCTION OF HEPATITIS B VIRUS MOTHER TO CHILD TRANSMISSION IN UGANDA | 2022 |
| Integral Global Consulting | Atlanta, GA | $377,900 | SUPPORT THE PROJECT "MITIGATING THE SPREAD OF COVID-19 IN GARMENT FACTORIES" | 2020 |
| New Discovery Llc | Flushing, NY | $371,612 | TDF IN COMBINATION WITH HBV VACCINE WITH OMISSION OF HBIG | 2018 |
Looking for more funders like The John Martin Foundation? Open the free Texas funder database and search 178,000+ foundations by state, type, and giving size.
Want to compare open opportunities instead? Open the free Texas grant database for active grants from federal, state, foundation, and corporate funders.